Good MorningEquity markets hovered near recent highs and above the critical near-term support target as participants awaited the Presidential election's outcome. The polls were neck and neck going into the event, leaving the market with nothing to do but wait. Regardless of the election, the stock market will likely continue to rally because of earnings growth, cash flow, and capital returns. The rally in equities may gain momentum in the back half of 2025 as the tailwind of falling interest rates begins to lift consumer spirits.
Shares of NVIDIA will likely lift the market later this week. The AI powerhouse is slated for inclusion in the Dow Jones Industrial Index starting on Friday, before the opening of trading. This means that billions in mutual funds and ETF capital will have to buy NVDA shares to remain indexed to the blue benchmark. The latest data shows that more than 3,600 funds were indexed to the Dow, so buying could be vigorous. NVIDIA also reports Q3 earnings report later this month. The latest business news about NVIDIA is that it is requesting inventory builds of HBM3 memory be advanced by 6 months, suggesting the AI data center business continues to gain momentum. Featured: INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad) 
|
Stocks | | | U.S. stocks drifted lower Monday ahead of a momentous week full of potential flashpoints in Washington, D.C., and around the world. The S&P 500 slipped 0.3%, though it remains near its record set last month. The Dow Jones Industrial Average fell 257 points, or 0.6%, while the Nasdaq composite ... Read the Full Story |
|
From Our Partners | | The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...
Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs.
One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. | | Click here to see the Tesla shock that could blindside everyone. |
|
Markets | | | With many of the Magnificent 7 stocks reporting earnings the week of October 28, investors’ attention was on technology stocks. But that means you may have overlooked two biopharmaceutical companies that delivered solid earnings reports.
Merck & Co. Inc. (NYSE: MRK) and The Bristol... Read the Full Story |
|
Markets | | |
Intel Corp (NASDAQ: INTC) has endured a tough year, with its stock losing as much as nearly 65% due to red-hot competition and declining earnings. However, in recent weeks, the stock has been consolidating and has even started to show signs of rally potential.
Santa Clara-based Intel, a s... Read the Full Story |
|
|
Markets | | |
As the Fed starts its interest rate cut cycle, many dynamic factors historically come into play. Rate cuts tend to stimulate consumer spending and construction activity since borrowing costs get cheaper. The housing market is expected to see more demand as mortgage rates fall. The IPO calendar get... Read the Full Story |
|
Markets | | | Saudi Arabian oil giant Aramco reported third-quarter profits of $27.5 billion on Tuesday, down about 15% from last year as low oil prices ate into its revenues. Aramco, formally known as the Saudi Arabian Oil Co., had revenues of $111.1 billion over the quarter, the company said in a filing on Riya... Read the Full Story |
|
From Our Partners | | 2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | |
Summit Therapeutics Inc. (NASDAQ: SMMT) is a development-stage biotech company specializing in novel therapies for oncology and infectious diseases. Their leading drug candidate is Ivonescimab, an immunotherapy treatment being tested on non-small cell lung cancer (NSCLC). The stock is trading up... Read the Full Story |
|
Markets | | | For some television viewers, size apparently does matter. Forget the 65-inch TVs that were considered bigger than average a decade ago. In time for the holidays, manufacturers and retailers are rolling out more XXL screens measuring more than 8 feet diagonally. That's wider than a standard three-sea... Read the Full Story |
|
Markets | | | Sobs of relief broke out in a federal courtroom in Kansas on Monday as dozens of people whose life savings had been embezzled by a bank CEO learned that federal law enforcement had recovered their money."I just can’t describe the weight lifted off of us,” said Bart Camilli, 70, who with his wife Cle... Read the Full Story |
|
Markets | | | No one knows how Tuesday’s presidential election will turn out, but the Federal Reserve’s move two days later is much easier to predict: With inflation continuing to cool, the Fed is set to cut interest rates for a second time this year Read the Full Story |
|
Markets | | |
The cruise operators were unfortunately locked into an epicenter industry in the consumer discretionary sector during the COVID-19 pandemic. The spread of the disease onboard cruise ships spurred fears that no one would ever want to take a cruise again and risk catching a fatal infection. Fast for... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications. It also offers beauty services, including hair, makeup, brow, and skin services at its stores. The company was formerly known as ULTA Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois. | Should I Buy Ulta Beauty Stock? ULTA Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Ulta Beauty was last updated on Monday, July 14, 2025 at 7:31 PM.
Ulta Beauty Bull Case -
Ulta Beauty, Inc. reported a strong earnings per share (EPS) of $6.70 for the latest quarter, significantly exceeding analysts' expectations, indicating robust financial performance.
-
The company has a high return on equity of nearly 50%, suggesting effective management and a strong ability to generate profits from shareholders' investments.
-
Recent revenue growth of 4.5% compared to the same quarter last year demonstrates the company's ability to expand its market presence and attract more customers.
-
Analysts have a consensus rating of "Moderate Buy" for Ulta Beauty, Inc., with a target price around $465.04, indicating positive sentiment and potential for stock appreciation.
-
The current stock price is approximately $510, reflecting investor confidence and a favorable market position for the company.
Ulta Beauty Bear Case -
Despite strong earnings, one analyst has issued a sell rating, which may indicate potential concerns about future performance or market conditions.
-
Some analysts have downgraded their ratings, suggesting that there may be challenges ahead that could impact the stock's performance.
-
With a net margin of 10.45%, there may be concerns about profitability in a competitive retail environment, which could affect long-term growth.
-
Market volatility and economic uncertainties could pose risks to consumer spending, potentially impacting Ulta Beauty, Inc.'s sales and revenue growth.
-
While the stock has a positive outlook, any significant market corrections could lead to a decline in stock price, affecting investor returns.
| | View Today's Stock Pick |
|
